Loading stock data…
HOYA CORP (7741.T)
TSE¥25,470-105.00 (-0.41%)
Market OpenUpdated 12:12 AM EDT
HOYA Corporation, a med-tech company, provides high-tech and medical products internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
HOYA Corporation in the Healthcare sector is trading at ¥25,470 with a market capitalization of $8.8T. Wall Street consensus targets ¥30,380 (15 analysts), implying a +19.3% move over the next 12 months. The stock is currently 16% below its 52-week high of ¥30,400, remaining 0.9% above its 200-day moving average. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +19.3% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Annual Financials
| Metric (JPY) · Annual | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
| Total Revenue | ¥734.10B↓ | ¥792.63B↓ | ¥885.82B↓ | ¥995.84B |
| Gross Profit | ¥631.86B↓ | ¥687.99B↓ | ¥766.25B↓ | ¥859.94B |
| Operating Income | ¥400.86B↓ | ¥433.45B↓ | ¥480.79B↓ | ¥551.13B |
| Net Income | ¥168.64B↓ | ¥181.38B↓ | ¥202.10B↓ | ¥253.08B |
Peer Comparison
JNJUNHPFE
Fundamentals
HOYA Corporation, a med-tech company, provides high-tech and medical products internationally. It operates through two segments: Life Care, and Information and Communications. It offers life care products, including eyeglasses and contact lenses; med...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
¥8.80T
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
35.41
Beta
Defensive asset. Lower volatility than the S&P 500.
0.64
Div Yield
Strong income play. Yield provides a meaningful total return floor.
112.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
25.06%
Volume
Today's trading volume
440,200
Recent News
Hoya (TSE:7741) Stock After New FDA Clearance Weighing Rich Valuation Against Growth Potential
FDA clearance puts HOYA (TSE:7741) endoscopy devices in focus HOYA (TSE:7741) has received US FDA clearance for new PENTAX Medical i20c Video Endoscope models, enabling use in US gastrointestinal endoscopy and drawing fresh attention to the stock’s medical device exposure. See our latest analysis for HOYA. The FDA news lands after a mixed period for the stock, with the share price at ¥26,420, a 1-day share price return of 3.0%, a 30-day share price return down 5.7%, and a 1-year total...
Hoya (TSE:7741) Stock After 60% Rise Is The Rally Losing Steam?
Investors may be wondering whether HOYA's share price still offers value after a strong run, or if most of the potential upside is already reflected in the stock. HOYA closed at ¥26,420, with the stock up 0.3% over the last week, down 4.5% over the last month, up 9.5% year to date and up 60.6% over the past year. Recent coverage has focused on HOYA's position in healthcare equipment and related optical technologies, which has kept interest in the stock elevated. This context helps explain...
DKILY vs. HOCPY: Which Stock Is the Better Value Option?
DKILY vs. HOCPY: Which Stock Is the Better Value Option?
TKR or HOCPY: Which Is the Better Value Stock Right Now?
TKR vs. HOCPY: Which Stock Is the Better Value Option?
HAYW vs. HOCPY: Which Stock Is the Better Value Option?
HAYW vs. HOCPY: Which Stock Is the Better Value Option?